Investment9 Sept 2026, 11:00 pm
RPG Life Sciences Subsidiary Allots Securities for ₹243.33 Cr
AI Summary
RPG Life Sciences Ltd announced that its wholly owned subsidiary, RPG Active Pharma Limited (RPGAP), has successfully allotted securities to India Life Sciences Fund IV Domestic (ILSF) and Vistaject Fund (VJF). This allotment, valued at INR 243.33 crores, represents 40% of RPGAP's equity share capital. The transaction is in line with the Investment and Shareholders' Agreement executed on July 29, 2026. Following this investment, RPGAP continues to remain a subsidiary of RPG Life Sciences Ltd. The company has informed the stock exchanges about the completion of this significant funding round.
Key Highlights
- RPGAP allotted securities for ₹243.33 Cr.
- Investors ILSF and VJF acquired 40% equity in RPGAP.
- Investment aligns with the July 29, 2026 Shareholders' Agreement.
- RPGAP remains a subsidiary of RPG Life Sciences Ltd.
- The deal signifies substantial capital infusion into the subsidiary.
Price Impact
More from RPGLIFE